The novel treatment of this peptide represents a major development in the management of the condition. Unlike existing drugs, tirzepatide affects dual pathways – the GLP-1 hormone and glucose-dependent insulinotropic https://tirzepatidepeptide499527.newsbloger.com/42638017/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment